Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330 (19 February), doi:10.1136/bmj.330.7488.0
People taking selective serotonin reuptake inhibitors (SSRIs) are more likely to attempt suicide than people taking placebo or a non-SSRI drug. Fergusson and colleagues (p 396) systematically reviewed 702 randomised controlled trials including 87 650 participants. They found significantly higher odds of suicide attempts for SSRIs than for placebo (number needed to treat to harm 684) and for therapeutic interventions other than tricyclic antidepressants (239). The meta-analysis did not detect a difference between SSRIs and tricyclic antidepressants. A number of major methodological limitations of the published trials may have led to underestimates of the risk of suicide attempts, say the authors.
|
|
Credit: LESLEY AGGAR/TREVILLION
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+